Health Union Announces Winners of 2024 Social Health Awards
Winners exemplify impact of social health on the healthcare industry, will be celebrated in-person at Fierce Pharma Marketing Awards
Published June 26, 2024 | 3 Minute Read
PHILADELPHIA — June 26, 2024 — Health Union, the leader in social health, has announced the 2024 class of Social Health Awards honorees. By empowering and celebrating the health leaders who are essential to the ongoing conversations and connections within the healthcare industry, the Social Health Awards continue to elevate the importance of social health – the dynamic, real-time action people take to find meaningful connections and share information that impacts the health journey.
Health leaders were nominated across 10 categories designed to showcase the vast diversity of the patient and caregiver community and the various forms of advocacy across all condition areas and platforms. The winners, whose profiles and accomplishments can be viewed here, in each category are:
- Advocacy Trailblazer: Emmitt Henderson
- Best Team: HeartCharged
- Caregiving Champion: Andrea Jensen
- Community Cultivator: Gracefully Jen
- Creative Contributor: Brittany “A Hot MS” Quiroz
- Healthcare Collaborator: Michael Donohoe
- Lifetime Achievement: Rwenshaun Miller
- Revolutionary Researcher: Dr. Andrea Vassilev
- Rookie of the Year: Danielle Connolly
- Social Media Master: Tiffany Kairos
“The Social Health Awards provide the unique opportunity to celebrate, recognize, and amplify the passion and dedication of health leaders who are truly models of social health,” said Amrita Bhowmick, Health Union’s chief strategy officer. “In addition to their hard work and advocacy within their individual condition communities, the 2024 honorees are showing – and will continue to show – the overwhelming impact they have on the healthcare industry.”
Nominations for the Social Health Awards were open to patient and caregiver leaders worldwide who are making a difference in healthcare as active members of an online community and are at least 18 years old. Nominees were first judged by their peers to determine the six finalists for each category. The 60 finalists were then evaluated by healthcare industry thought leaders to determine the winners. The honorees were announced on June 24, 2024 during Connexion, a Health Union virtual event that connects and empowers patient leaders.
The winners are invited to join Health Union on stage at the Social Health Awards celebration at the 2024 Fierce Pharma Marketing Awards ceremony, which will occur this September at the annual Digital Pharma East conference in Philadelphia. More information about the Social Health Awards can be found at SocialHealthAwards.com.
About Health Union
Health Union is the proven industry leader driving and amplifying social health. As the premier social health company, only Health Union encourages the dynamic, real-time action people take to find meaningful connections and share information that impact their health journey. The company reaches millions of people through the largest portfolio of condition-specific online health communities (e.g., Migraine.com, MultipleSclerosis.net, LungCancer.net) and health leaders – addressing virtually every condition and providing the information, connection and support they need.
Related Articles
Patient Centricity Starts With Patients: Closing the Trial Recruitment Gap
There is a lot of talk in the industry about patient centricity, but is it the reality? We talk about putting the needs of patients first and keeping them central in the business decisions we make across the healthcare industry. However, as we discussed on a panel at this year’s DIA 2018 Global Annual Meeting, somehow in the effort to amplify patient centricity, a critical voice is often underrepresented—the voice of the patient.
Building Relationships vs. Publishing Content: Reflecting on the Renewed Interest In Migraine Disease
A new class of migraine drugs, called anti-CGRPs (calcitonin gene-related peptide) are expected to reinvigorate a market that has been largely dormant for some time. Four biopharma companies, Amgen, Teva, Lilly and Alder are entering the fray. Not surprisingly, the intense competition and pharma investment associated with this market dynamic has led traditional “eyeball driven” publishers, like WebMD, Everyday Health and others on a quest to offer substantially more migraine-related content in reaction to this market opportunity.
What People Fear the Most About Their Future With Asthma
“Asthma In America 2018” asked questions about diagnosis, medications, treatments and more to over 800 respondents. Surprisingly, the survey revealed four things people with asthma fear most about their future, all of which have a profound impact on the way they view their condition and rate their quality of life.
Related Articles
Nothing Found
Sorry, no posts matched your criteria